Clin Eval 49 Suppl XXXVIII 2021

COVID-19 and bioethics Part 3:

Pandemic and research ethics – Democracy, placebo and post-trial access

Agenda and participants
Opening Remarks by organizers and moderators
Opening Remarks of the Day 1 (page 14) and Day 2 (page 61)

Dirceu Greco

Takeo Saio, MD

Dirceu Greco, MD, PhD

COVID-19 Task Force, Japan Association for
Bioethics
Department of Internal Medicine and Psychiatry,
Fuji Toranomon Orthopedic Hospital

Chair, Brazilian Society of Bioethics
Professor Emeritus, Infectious Diseases andBioethics, Federal University of Minas Gerais,
BrazilKyoko Imamura, MD, PhD

Past President of the International Federation of Associations ofPharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) andformer President of the Japanese Association of PharmaceuticalMedicine (JAPhMed)
Project Professor, Social Cooperation Program of IT Healthcare, The
Graduate School of Pharmaceutical Sciences, The University of Tokyo;
Japanese Institute for Public Engagement
Kyoko Imamura

Special guests
Comments at the Day 1 and Day 2 discussion sessions (page 42, 51, 78, 103)

Ramin Parsa-Parsi

Otmar Kloiber

Ramin Parsa-Parsi, MD, MPH

Otmar Kloiber, MD, PhD

Workgroup Chair of the 2013 revision of theDeclaration of Helsinki, World Medical Association;
German Medical Association

Secretary General, World Medical Association− 11 −

臨床評価49 巻

別冊2021

Presentations in Day 1

Chieko Kurihara, BSocSc

COVID-19 Task Force, Japan Association for Bioethics
Specially-appointed Professor, Kanagawa Dental
University, Japan“Opening remarks and situation in Japan and theworld: Proposal on ethics of placebo-controlled trials
and post-trial access in the Declaration of Helsinki”(page 16)

Ruth Macklin, PhD

Distinguished University Professor Emerita at
Albert Einstein College of Medicine in New York
City, the United States“Ethics in vaccine research: the COVID-19
pandemic” (page 24)

Peter LuriePeter Lurie, MD, MPH

Center for Science in the Public Interest, Washington,
DC, the United States“Revisiting the debate over placebo use in developing
countries in the age of COVID-19” (page 30)

Ulf Schmidt, PhD

Professor of Modern History, University ofHamburg, Germany“From Nuremberg to Helsinki: Historicising
Research Ethics during Health crisis” (page 45)

DiscussantsComments at the Day 1 and Day 2 discussion sessions (page 51, 103)

Rihito Kimura, LLM, PhD

Professor Emeritus of Bioethics, Waseda University, Japan
Faculty Affiliate, Kennedy Institute of Ethics, Georgetown
University, the United States− 12 −

Sandor Kerpel-Fronius, MD, PhD

Professor of Clinical Pharmacology, Semmelweis
University, Hungary

Clin Eval 49 Suppl XXXVIII 2021

Presentations in Day 2

Ames Dhai

Tammam Aloudat

Ames Dhai, MD, PhD

Tammam Aloudat, MD, MPH

Dirceu Greco, MD, PhD

Francis P. Crawley

Professor of Bioethics, University of the
Witwatersrand, Johannesburg, South Africa“Ethics in vaccine allocation in developing
countries” (page 63)

Managing Director, Global Health Center, Graduate
Institute of International Development Studies,Geneva, Switzerland“Médecins Sans Frontières (MSF) AccessCampaign for equitable access in the world”(page 72)

Professor Emeritus, Infectious Diseases andBioethics, Federal University of Minas Gerais,
Brazil“Post-Trial Access for All: Perspective of achieving universal access to adequate public health”(page 82)

Executive Director of the Good Clinical PracticeAlliance – Europe (GCPA) and Strategic Initiativefor Developing Capacity in Ethical Review(SIDCER), Leuven, Belgium“Learnings for ethics from COVID-19” (page 94)

Special thanks toWe express special thanks to organizers and supporting organizations.
Co-organized by the COVID-19 Task Force, Japan Association for Bioethics and the Brazilian Society ofBioethics
Supported by the Japanese Association of Pharmaceutical Medicine (JAPhMed) and the International
Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP)
Cooperation:
Clinical Evaluation; Bioethics Policy Study Group; Pharmaceutical Study Group
Clinical Research Risk Management Study GroupVideo-recorded versions and other related information can be accessed from the following web-site:
http://cont.o.oo7.jp/sympo/covidandbioethics.html− 13 −